ATE417930T1 - Proteinkinase npk-110 - Google Patents
Proteinkinase npk-110Info
- Publication number
- ATE417930T1 ATE417930T1 AT95937855T AT95937855T ATE417930T1 AT E417930 T1 ATE417930 T1 AT E417930T1 AT 95937855 T AT95937855 T AT 95937855T AT 95937855 T AT95937855 T AT 95937855T AT E417930 T1 ATE417930 T1 AT E417930T1
- Authority
- AT
- Austria
- Prior art keywords
- protein kinase
- npk
- alzheimer
- maps
- cancer
- Prior art date
Links
- 102000001253 Protein Kinase Human genes 0.000 title abstract 4
- 108060006633 protein kinase Proteins 0.000 title abstract 3
- 108091077621 MAPRE family Proteins 0.000 abstract 3
- 102000009664 Microtubule-Associated Proteins Human genes 0.000 abstract 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 101000941893 Felis catus Leucine-rich repeat and calponin homology domain-containing protein 1 Proteins 0.000 abstract 1
- 102000029749 Microtubule Human genes 0.000 abstract 1
- 108091022875 Microtubule Proteins 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 210000004688 microtubule Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000013498 tau Proteins Human genes 0.000 abstract 1
- 108010026424 tau Proteins Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94117122 | 1994-10-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE417930T1 true ATE417930T1 (de) | 2009-01-15 |
Family
ID=8216419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95937855T ATE417930T1 (de) | 1994-10-28 | 1995-10-30 | Proteinkinase npk-110 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6579691B1 (de) |
| EP (1) | EP0791067B1 (de) |
| JP (1) | JPH10508199A (de) |
| KR (1) | KR100275591B1 (de) |
| CN (1) | CN1168699A (de) |
| AT (1) | ATE417930T1 (de) |
| CA (1) | CA2203910A1 (de) |
| DE (1) | DE69535901D1 (de) |
| HU (1) | HUT77081A (de) |
| NO (1) | NO971966L (de) |
| NZ (1) | NZ295371A (de) |
| WO (1) | WO1996013592A2 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993011231A1 (en) * | 1991-12-06 | 1993-06-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Tools for the diagnosis and treatment of alzheimer's disease |
| AU6421498A (en) * | 1997-04-28 | 1998-11-24 | Helix Research Institute | Serine/threonine protein kinase |
| WO2001081558A2 (en) * | 2000-04-25 | 2001-11-01 | Millennium Pharmaceuticals, Inc. | 13295 novel protein kinase molecules and uses therefor |
| AU2002239571A1 (en) * | 2000-12-06 | 2002-06-18 | Incyte Genomics, Inc. | Kinases and phosphatases sequences, and use thereof |
| US7119185B2 (en) * | 2000-12-21 | 2006-10-10 | Trustees Of The University Of Pennsylvania | Hormonally up-regulated, neu-tumor-associated kinase |
| ATE394115T1 (de) * | 2001-02-27 | 2008-05-15 | Brni Neurosciences Inst | Diagnose der alzheimer-krankheit auf basis von mitogenaktivierter proteinkinase-phosphorylierung |
| ATE483976T1 (de) | 2001-06-05 | 2010-10-15 | Exelixis Inc | Gfats als modifikatoren des p53-wegs und verwendungsverfahren |
| US6492156B1 (en) * | 2001-10-31 | 2002-12-10 | Pe Corporation (Ny) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| EP1633856A4 (de) * | 2003-06-19 | 2007-07-18 | Exelixis Inc | Marks als modifikatoren des pten-wegs und verwendungsverfahren |
| US8273536B2 (en) | 2003-06-19 | 2012-09-25 | Exelixis, Inc. | Marks as modifers of the PTEN pathway and methods of use |
| CN100424184C (zh) * | 2005-12-09 | 2008-10-08 | 浙江大学 | 疱疹类病毒基因芯片及其应用 |
| US9433922B2 (en) * | 2007-08-14 | 2016-09-06 | Emd Millipore Corporation | Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same |
| KR101294725B1 (ko) * | 2010-12-30 | 2013-08-08 | 연세대학교 산학협력단 | 인산화된 ｇｒａｓｐ를 포함하는 낭포성섬유증 치료용 약학 조성물 |
| US9518101B2 (en) * | 2011-09-19 | 2016-12-13 | Axon Neuroscience Se | Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
| EP3658172A4 (de) | 2017-07-25 | 2021-05-05 | TrueBinding, Inc. | Behandlung von krebs durch blockierung der interaktion von tim-3 und seinem liganden |
| CN113711036B (zh) | 2019-01-30 | 2025-03-18 | 真和制药有限公司 | 抗gal3抗体及其用途 |
| CN116157151A (zh) | 2020-05-26 | 2023-05-23 | 真和制药有限公司 | 通过阻断半乳凝素-3治疗炎性疾病的方法 |
| CN117551674B (zh) * | 2023-11-20 | 2024-10-18 | 内蒙古农业大学 | 沙葱萤叶甲微管亲和调节激酶GdMARK2基因的克隆及其功能 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0544942A1 (de) * | 1991-12-06 | 1993-06-09 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Neue Werkzeuge für die Diagnose und die Behandlung der Alzheimer-Krankheit |
-
1995
- 1995-10-30 HU HU9702175A patent/HUT77081A/hu unknown
- 1995-10-30 CA CA002203910A patent/CA2203910A1/en not_active Abandoned
- 1995-10-30 JP JP8514323A patent/JPH10508199A/ja not_active Ceased
- 1995-10-30 US US08/817,832 patent/US6579691B1/en not_active Expired - Fee Related
- 1995-10-30 CN CN95196569A patent/CN1168699A/zh active Pending
- 1995-10-30 EP EP95937855A patent/EP0791067B1/de not_active Expired - Lifetime
- 1995-10-30 KR KR1019970702885A patent/KR100275591B1/ko not_active Expired - Fee Related
- 1995-10-30 AT AT95937855T patent/ATE417930T1/de not_active IP Right Cessation
- 1995-10-30 DE DE69535901T patent/DE69535901D1/de not_active Expired - Lifetime
- 1995-10-30 NZ NZ295371A patent/NZ295371A/en unknown
- 1995-10-30 WO PCT/EP1995/004258 patent/WO1996013592A2/en not_active Ceased
-
1997
- 1997-04-28 NO NO971966A patent/NO971966L/no not_active Application Discontinuation
-
2003
- 2003-05-16 US US10/440,435 patent/US7485712B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| HUT77081A (hu) | 1998-03-02 |
| EP0791067A2 (de) | 1997-08-27 |
| CN1168699A (zh) | 1997-12-24 |
| KR100275591B1 (ko) | 2001-02-01 |
| US20040038361A1 (en) | 2004-02-26 |
| WO1996013592A3 (en) | 1996-08-01 |
| CA2203910A1 (en) | 1996-05-09 |
| MX9703101A (es) | 1998-07-31 |
| JPH10508199A (ja) | 1998-08-18 |
| NO971966D0 (no) | 1997-04-28 |
| DE69535901D1 (de) | 2009-01-29 |
| AU714636B2 (en) | 2000-01-06 |
| US6579691B1 (en) | 2003-06-17 |
| NO971966L (no) | 1997-06-19 |
| NZ295371A (en) | 1998-11-25 |
| US20030104516A1 (en) | 2003-06-05 |
| US7485712B2 (en) | 2009-02-03 |
| EP0791067B1 (de) | 2008-12-17 |
| WO1996013592A2 (en) | 1996-05-09 |
| AU3870295A (en) | 1996-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69535901D1 (de) | Proteinkinase npk-110 | |
| AU2001294541A1 (en) | Mammalian genes; related reagents and methods | |
| EP0683234A4 (de) | ANTIKÖRPER GEGEN -g(b)-AMYLOID ODER DERIVATE DAVON UND SEINE VERWENDUNG. | |
| EP0909814A3 (de) | Verwendung von Proteinkinasen zur Diagnose und Behandlung der Alzheimer'schen Krankheit | |
| AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
| PT737207E (pt) | Inibidores de plasmina humana derivados de dominios kunitz | |
| DE69435038D1 (de) | Aktivin rezeptor-ähnliche kinase (alk), gehörend zur tgf rezeptorfamilie und/oder zur bmp rezeptorfamilie | |
| MX9709913A (es) | Metaloconstrucciones determinadas estructuralmente y aplicaciones. | |
| WO2002057259A3 (en) | Pyrazole compounds useful as protein kinase inhibitors | |
| EA200101037A1 (ru) | Соединения и способы для лечения и диагностики рака легкого | |
| DK1005540T3 (da) | IKK-beta-proteiner, nukleinsyrer og fremgangsmåder | |
| BR9609521A (pt) | Fator de crescimento de tecido conectivo | |
| MXPA02008239A (es) | Gen humano de la esquizofrenia. | |
| ATE212065T1 (de) | Nukleinsäuremoleküle mit der fähigkeit zur unterscheidung von prpc und prpsc-prionprotein- isoformen und verfahren zu deren herstellung | |
| WO2003028543A3 (en) | Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease | |
| WO2003105773A3 (en) | Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets: | |
| DE69728897D1 (de) | Saeugetierchemokine | |
| WO2001057219A3 (en) | Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods | |
| EP0815240A4 (de) | Neue menschliche proteine, die cyclinebhängigen kinasen ähneln, sowie methoden zu deren verwendung | |
| DE69621837D1 (de) | Methoden zur feststellung von alzheimerscher krankheit | |
| WO2001064876A3 (en) | Human schizophrenia gene | |
| EP0780472A3 (de) | Stress Proteine | |
| WO2003060067A3 (en) | P85-alpha nucleic acids, polypeptides and related methods | |
| WO2002072626A3 (de) | Neue form des phgpx-proteins als diagnostischer marker bei männlicher infertilität | |
| WO2001090156A3 (en) | Card domain containing polypeptides, encoding nucleic acids, and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |